[Federal Register Volume 85, Number 211 (Friday, October 30, 2020)]
[Notices]
[Page 68890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24126]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Ninth Meeting of the National Clinical Care Commission

AGENCY: Office on Women's Health, Office of the Assistant Secretary for 
Health, Office of the Secretary, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The National Clinical Care Commission (the Commission) will 
conduct its ninth meeting virtually on November 17, 2020. The 
Commission is charged to evaluate and make recommendations to the U.S. 
Department of Health and Human Services (HHS) Secretary and Congress 
regarding improvements to the coordination and leveraging of federal 
programs related to diabetes and its complications.

DATES: The meeting will take place on November 17, 2020, from 1 p.m. to 
approximately 5:30 p.m. Eastern Standard time (EST).

ADDRESSES: The meeting will be held online via webinar. To register to 
attend the meeting, please visit the registration website at https://kauffmaninc.adobeconnect.com/nccc_9/event/event_info.html.

FOR FURTHER INFORMATION CONTACT: Clydette Powell, M.D., M.P.H., 
F.A.A.P., Designated Federal Officer, National Clinical Care 
Commission, U.S. Department of Health and Human Services, Office on 
Women's Health, 200 Independence Ave. SW 7th Floor, Washington DC 
20201. Phone: (240) 453-8239. Email: [email protected].

SUPPLEMENTARY INFORMATION: The National Clinical Care Commission Act 
(Pub. L. 115-80) requires the HHS Secretary to establish the National 
Clinical Care Commission. The Commission consists of representatives of 
specific federal agencies and non-federal individuals who represent 
diverse disciplines and views. The Commission will evaluate and make 
recommendations to the HHS Secretary and Congress regarding 
improvements to the coordination and leveraging of federal programs 
related to diabetes and its complications.
    The ninth meeting will be held virtually and will consist of 
updates from the Commission's three subcommittees and a discussion of 
public comments and outreach to stakeholder organizations. 
Additionally, the Commission will discuss the second round of potential 
``action plans'' from the subcommittees (i.e., recommendations). The 
final meeting agenda will be available prior to the meeting at https://health.gov/our-work/health-care-quality/national-clinical-care-commission/meetings.
    Public Participation at Meeting: The Commission invites public 
comment on issues related to the Commission's charge. There will be an 
opportunity for limited oral comments (each no more than 3 minutes in 
length) at this virtual meeting. Virtual attendees who plan to provide 
oral comments at the Commission meeting during a designated time must 
register prior to the meeting at https://kauffmaninc.adobeconnect.com/nccc_9/event/event_info.html.
    Written comments are welcome throughout the entire development 
process of the Commission's work and may be emailed to [email protected]. 
Written comments should not exceed three pages in length.
    Individuals who need special assistance, such as sign language 
interpretation or other reasonable accommodations, should indicate the 
special accommodation when registering online or by notifying Jennifer 
Gillissen at [email protected] by November 9, 2020.

    Authority:  The National Clinical Care Commission is required 
under the National Clinical Care Commission Act (Pub. L. 115-80). 
The Commission is governed by provisions of the Federal Advisory 
Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C., App.) 
which sets forth standards for the formation and use of federal 
advisory committees.

    Dated: October 27, 2020.
Dorothy Fink,
Deputy Assistant Secretary for Women's Health, Office of the Assistant 
Secretary for Health.
[FR Doc. 2020-24126 Filed 10-29-20; 8:45 am]
BILLING CODE 4150-32-P